Christopher Riley

637 total citations
11 papers, 514 citations indexed

About

Christopher Riley is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Christopher Riley has authored 11 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Christopher Riley's work include Lymphoma Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Christopher Riley is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Christopher Riley collaborates with scholars based in United States, Netherlands and United Kingdom. Christopher Riley's co-authors include Kimiko Della Croce, Daruka Mahadevan, Laurence Cooke, David J. Bearss, Kishore Shakalya, Raymond B. Nagle, Brian W. Simons, Rachel Swart, Lee Wisner and Marilena V. Iorio and has published in prestigious journals such as Cancer Research, Oncogene and British Journal of Cancer.

In The Last Decade

Christopher Riley

11 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Riley United States 8 179 177 145 117 101 11 514
Eric Cheung United States 11 96 0.5× 244 1.4× 57 0.4× 112 1.0× 228 2.3× 21 498
S. Öhl Germany 13 216 1.2× 234 1.3× 179 1.2× 106 0.9× 378 3.7× 19 778
Guosheng Lin China 11 276 1.5× 94 0.5× 217 1.5× 109 0.9× 20 0.2× 25 555
Thomas Mühlenberg Germany 15 336 1.9× 168 0.9× 38 0.3× 279 2.4× 55 0.5× 28 725
Jianling Zou China 14 200 1.1× 243 1.4× 64 0.4× 119 1.0× 52 0.5× 18 467
Ruixuan Geng China 12 234 1.3× 254 1.4× 66 0.5× 196 1.7× 54 0.5× 29 556
Masako Uno Japan 12 180 1.0× 148 0.8× 38 0.3× 87 0.7× 19 0.2× 38 528
Koki Nagaike Japan 11 207 1.2× 110 0.6× 41 0.3× 61 0.5× 36 0.4× 20 529
Andrea Ravelli Italy 10 200 1.1× 288 1.6× 53 0.4× 251 2.1× 70 0.7× 15 543
Jennifer A. Grabowsky United States 12 389 2.2× 274 1.5× 67 0.5× 104 0.9× 56 0.6× 29 634

Countries citing papers authored by Christopher Riley

Since Specialization
Citations

This map shows the geographic impact of Christopher Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Riley more than expected).

Fields of papers citing papers by Christopher Riley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Riley. The network helps show where Christopher Riley may publish in the future.

Co-authorship network of co-authors of Christopher Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Riley. A scholar is included among the top collaborators of Christopher Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Riley. Christopher Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Agarwal, Amit, et al.. (2014). Genetic and cytokine changes associated with symptomatic stages of CLL. Leukemia Research. 38(9). 1097–1101. 5 indexed citations
2.
Qi, Wenqing, Christopher Riley, Kimiko Della Croce, et al.. (2009). MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer. BMC Cancer. 9(1). 142–142. 40 indexed citations
3.
4.
Riley, Christopher, K. Engelhardt, José W. Saldanha, et al.. (2009). Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer. Cancer Research. 69(5). 1933–1940. 33 indexed citations
5.
Mahadevan, Daruka, Laurence Cooke, Christopher Riley, et al.. (2007). A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene. 26(27). 3909–3919. 224 indexed citations
6.
Mahadevan, Daruka, Kimiko Della Croce, Christopher Riley, et al.. (2006). Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. American Journal of Hematology. 81(10). 779–786. 26 indexed citations
7.
Engelhardt, K., Christopher Riley, Laurence Cooke, & Daruka Mahadevan. (2006). Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma. Current Drug Discovery Technologies. 3(4). 231–243. 7 indexed citations
8.
Dvořáková, Kateřina, Claire M. Payne, Lois Ramsey, et al.. (2005). Apoptosis Resistance in Barrett's Esophagus: Ex vivo Bioassay of Live Stressed Tissues. The American Journal of Gastroenterology. 100(2). 424–431. 42 indexed citations
9.
Mahadevan, Daruka, Catherine Spier, Kimiko Della Croce, et al.. (2005). Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Molecular Cancer Therapeutics. 4(12). 1867–1879. 73 indexed citations
10.
Riley, Christopher, et al.. (1995). Ceroid granulomas in the female genital system.. Journal of Clinical Pathology. 48(11). 1057–1059. 5 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Cheung Breakdown of academic impact, for papers by S. Öhl Breakdown of academic impact, for papers by Guosheng Lin Breakdown of academic impact, for papers by Thomas Mühlenberg Breakdown of academic impact, for papers by Jianling Zou Breakdown of academic impact, for papers by Ruixuan Geng Breakdown of academic impact, for papers by Masako Uno Breakdown of academic impact, for papers by Koki Nagaike Breakdown of academic impact, for papers by Andrea Ravelli Breakdown of academic impact, for papers by Jennifer A. Grabowsky
Rankless by CCL
2026